Assessing the efficacy of our ITGB4-DC vaccine in these two tumor models, we found that vaccination combined with anti-PD-L1 immunotherapy significantly reduced tumor growth and inhibited spontaneous pulmonary metastasis better than each monotherapy. Here, ITGB4 is linked to neoplasm.